001027034 001__ 1027034
001027034 005__ 20250204113901.0
001027034 0247_ $$2doi$$a10.1053/j.ajkd.2023.11.007
001027034 0247_ $$2ISSN$$a0272-6386
001027034 0247_ $$2ISSN$$a1523-6838
001027034 0247_ $$2datacite_doi$$a10.34734/FZJ-2024-03600
001027034 0247_ $$2pmid$$a38184092
001027034 0247_ $$2WOS$$aWOS:001260318200001
001027034 037__ $$aFZJ-2024-03600
001027034 082__ $$a610
001027034 1001_ $$00000-0003-4781-6480$$aSuárez, Victor$$b0
001027034 245__ $$aChronic Hyponatremia and Brain Structure and Function Before and After Treatment
001027034 260__ $$aPhiladelphia, Pa.$$bElsevier Saunders$$c2024
001027034 3367_ $$2DRIVER$$aarticle
001027034 3367_ $$2DataCite$$aOutput Types/Journal article
001027034 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1719549754_18919
001027034 3367_ $$2BibTeX$$aARTICLE
001027034 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001027034 3367_ $$00$$2EndNote$$aJournal Article
001027034 520__ $$aRationale & objective: Hyponatremia is the most common electrolyte disorder and is associated with significant morbidity and mortality. This study investigated neurocognitive impairment, brain volume, and alterations in magnetic resonance imaging (MRI)-based measures of cerebral function in patients before and after treatment for hyponatremia.Study design: Prospective cohort study.Setting & participants: Patients with presumed chronic hyponatremia without signs of hypo- or hypervolemia treated in the emergency department of a German tertiary-care hospital.Exposure: Hyponatremia (ie, plasma sodium concentration [Na+]<125mmol/L) before and after treatment leading to [Na+]>130mmol/L.Outcomes: Standardized neuropsychological testing (Mini-Mental State Examination, DemTect, Trail Making Test A/B, Beck Depression Inventory, Timed Up and Go) and resting-state MRI were performed before and after treatment of hyponatremia to assess total brain and white and gray matter volumes as well as neuronal activity and its synchronization.Analytical approach: Changes in outcomes after treatment for hyponatremia assessed using bootstrapped confidence intervals and Cohen d statistic. Associations between parameters were assessed using correlation analyses.Results: During a 3.7-year period, 26 patients were enrolled. Complete data were available for 21 patients. Mean [Na+]s were 118.4mmol/L before treatment and 135.5mmol/L after treatment. Most measures of cognition improved significantly. Comparison of MRI studies showed a decrease in brain tissue volumes, neuronal activity, and synchronization across all gray matter after normalization of [Na+]. Volume effects were particularly prominent in the hippocampus. During hyponatremia, synchronization of neuronal activity was negatively correlated with [Na+] (r=-0.836; 95% CI, -0.979 to-0.446) and cognitive function (Mini-Mental State Examination, r=-0.523; 95% CI, -0.805 to-0.069; DemTect, r=-0.744; 95% CI, -0.951 to-0.385; and Trail Making Test A, r=0.692; 95% CI, 0.255-0.922).Limitations: Small sample size, insufficient quality of several MRI scans as a result of motion artifact.Conclusions: Resolution of hyponatremia was associated with improved cognition and reductions in brain volumes and neuronal activity. Impaired cognition during hyponatremia is closely linked to increased neuronal activity rather than to tissue volumes. Furthermore, the hippocampus appears to be particularly susceptible to hyponatremia, exhibiting pronounced changes in tissue volume.Plain-language summary: Hyponatremia is a common clinical problem, and patients often present with neurologic symptoms that are at least partially reversible. This study used neuropsychological testing and magnetic resonance imaging to examine patients during and after correction of hyponatremia. Treatment led to an improvement in patients' cognition as well as a decrease in their brain volumes, spontaneous neuronal activity, and synchronized neuronal activity between remote brain regions. Volume effects were particularly prominent in the hippocampus, an area of the brain that is important for the modulation of memory. During hyponatremia, patients with the lowest sodium concentrations had the highest levels of synchronized neuronal activity and the poorest cognitive test results.Keywords: Hyponatremia; cerebral edema; functional MRI; neuropsychological assessment.
001027034 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001027034 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001027034 7001_ $$0P:(DE-HGF)0$$aPicotin, Rosanne$$b1
001027034 7001_ $$0P:(DE-HGF)0$$aFassbender, Ronja$$b2
001027034 7001_ $$0P:(DE-HGF)0$$aGramespacher, Hannes$$b3
001027034 7001_ $$0P:(DE-HGF)0$$aHaneder, Stefan$$b4
001027034 7001_ $$0P:(DE-HGF)0$$aPersigehl, Thorsten$$b5
001027034 7001_ $$0P:(DE-HGF)0$$aTodorova, Polina$$b6
001027034 7001_ $$0P:(DE-HGF)0$$aHackl, Matthias Johannes$$b7
001027034 7001_ $$0P:(DE-HGF)0$$aOnur, Oezguer A.$$b8
001027034 7001_ $$0P:(DE-Juel1)167565$$aRichter, Nils$$b9$$ufzj
001027034 7001_ $$00000-0002-0256-6628$$aBurst, Volker$$b10$$eCorresponding author
001027034 773__ $$0PERI:(DE-600)2019205-8$$a10.1053/j.ajkd.2023.11.007$$gp. S0272638624000015$$n1$$pS0272638624000015$$tAmerican journal of kidney diseases$$v84$$x0272-6386$$y2024
001027034 8564_ $$uhttps://juser.fz-juelich.de/record/1027034/files/1-s2.0-S0272638624000015-main.pdf$$yOpenAccess
001027034 8564_ $$uhttps://juser.fz-juelich.de/record/1027034/files/1-s2.0-S0272638624000015-main.gif?subformat=icon$$xicon$$yOpenAccess
001027034 8564_ $$uhttps://juser.fz-juelich.de/record/1027034/files/1-s2.0-S0272638624000015-main.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
001027034 8564_ $$uhttps://juser.fz-juelich.de/record/1027034/files/1-s2.0-S0272638624000015-main.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
001027034 8564_ $$uhttps://juser.fz-juelich.de/record/1027034/files/1-s2.0-S0272638624000015-main.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
001027034 909CO $$ooai:juser.fz-juelich.de:1027034$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001027034 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)167565$$aForschungszentrum Jülich$$b9$$kFZJ
001027034 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001027034 9141_ $$y2024
001027034 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001027034 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-22
001027034 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001027034 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-22
001027034 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bAM J KIDNEY DIS : 2022$$d2024-12-10
001027034 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-10
001027034 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-10
001027034 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-10
001027034 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-10
001027034 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-10
001027034 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bAM J KIDNEY DIS : 2022$$d2024-12-10
001027034 920__ $$lyes
001027034 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
001027034 980__ $$ajournal
001027034 980__ $$aVDB
001027034 980__ $$aUNRESTRICTED
001027034 980__ $$aI:(DE-Juel1)INM-3-20090406
001027034 9801_ $$aFullTexts